Company Overview and News

24
Abbott (ABT) Beats on Earnings and Revenues in Q2

2018-07-18 zacks
Abbott Laboratories (ABT - Free Report) is an Illinois-based company focused on bringing a diverse line of healthcare products to the market.
ABT OCUL JAKK FTRPR ABT FTR

17
Grupo Simec (SIM) Catches Eye: Stock Jumps 7.1%

2018-07-18 zacks
Grupo Simec, S.A.B. de C.V. (SIM - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 17.1% in the past one-month time frame.
OCUL JAKK MT FTRPR MT FTR

18
Should You Buy E*TRADE (ETFC) Ahead of Earnings?

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season E*TRADE Financial Corporation (ETFC - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL JAKK FTRPR ETFC FTR

17
Should You Buy Union Pacific (UNP) Ahead of Earnings?

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Union Pacific Corporation (UNP - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL JAKK FTRPR UNP FTR

17
Why Earnings Season Could Be Great for Blackstone (BX)

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and The Blackstone Group L.P. (BX - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL JAKK FTRPR FTR

60
Luminex (LMNX) Looks Good: Stock Adds 5.7% in Session

2018-07-18 zacks
Luminex Corporation (LMNX - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 10.9% in the past one-month time frame.
OCUL JAKK FTRPR LMNX CHEK CHEKW FTR

17
Is a Surprise Coming for Cintas (CTAS) This Earnings Season?

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Cintas Corporation (CTAS - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL CTAS JAKK FTRPR FTR

18
Why Skyworks Solutions (SWKS) Might Surprise This Earnings Season

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season Skyworks Solutions, Inc. (SWKS - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
OCUL SWKS JAKK FTRPR FTR

17
Why Celanese (CE) Might Surprise This Earnings Season

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Celanese Corporation (CE - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Celanese is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for CE in this report.
OCUL JAKK FTRPR FTR CE

17
Should You Buy Alliance Data Systems (ADS) Ahead of Earnings?

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Alliance Data Systems Corporation (ADS - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Alliance Data Systems is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
OCUL JAKK FTRPR ADS FTR

17
Is a Surprise Coming for Domino's Pizza (DPZ) This Earnings Season?

2018-07-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Domino’s Pizza, Inc. (DPZ - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Domino’s Pizza is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
OCUL JAKK FTRPR FTR

17
Implied Volatility Surging for Denbury Resources (DNR) Stock Options

2018-07-18 zacks
Investors in Denbury Resources Inc. (DNR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $2.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
OCUL JAKK DNR FTRPR FTR

17
Options Traders Expect Huge Moves in 8x8, Inc. (EGHT) Stock

2018-07-18 zacks
Investors in 8x8, Inc. (EGHT - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $17.50 Put had some of the highest implied volatility of all equity options today.
OCUL JAKK FTRPR FTR

17
Options Traders Expect Huge Moves in Salesforce.com, Inc. (CRM) Stock

2018-07-18 zacks
Investors in Salesforce.com, Inc. (CRM - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $85 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
OCUL JAKK FTRPR CRM FTR

150
Are Options Traders Betting on a Big Move in Rite Aid (RAD) Stock?

2018-07-18 zacks
Investors in Rite Aid Corporation (RAD - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $2.00 Put had some of the highest implied volatility of all equity options today.
OCUL JAKK FTRPR RAD FTR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 35906A207